Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort

od Nishioka, Scott T., Sato, Miles M., Wong, Linda L., Tiirikainen, Maarit, Kwee, Sandi A.
Izdano u Hepatoma Res (2018)

Prediction of PSA progression in castrate-resistant prostate cancer based on treatment-associated change in tumor burden quantified by (18)F-fluorocholine PET/CT

od Lee, Joohee, Sato, Miles M., Coel, Marc N., Lee, Kyung-Han, Kwee, Sandi A.
Izdano u J Nucl Med (2016)

[(18)F]fluorocholine PET/CT imaging of liver cancer: radiopathologic correlation with tissue phospholipid profiling

od Kwee, Sandi A, Sato, Miles M, Kuang, Yu, Franke, Adrian, Custer, Laurie, Miyazaki, Kyle, Wong, Linda L
Izdano u Mol Imaging Biol (2017)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT

od Kwee, Sandi A., Wong, Linda L., Hernandez, Brenda Y., Chan, Owen T.M., Sato, Miles M., Tsai, Naoky
Izdano u Diagnostics (Basel) (2015)

Phospholipids are A Potentially Important Source of Tissue Biomarkers for Hepatocellular Carcinoma: Results of a Pilot Study Involving Targeted Metabolomics

od Evangelista, Erin B., Kwee, Sandi A., Sato, Miles M., Wang, Lu, Rettenmeier, Christoph, Xie, Guoxiang, Jia, Wei, Wong, Linda L.
Izdano u Diagnostics (Basel) (2019)

Transcriptomics associates molecular features with (18)F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.

od Kwee, Sandi A., Tiirikainen, Maarit, Sato, Miles M., Acoba, Jared D., Wei, Runmin, Jia, Wei, Le Marchand, Loic, Wong, Linda L.
Izdano u Cancer Res (2019)